Latest Breaking News On - Huntington disease hd program - Page 1 : comparemela.com

NeuBase Therapeutics Reports Business Update and Financial Results for the Second Quarter of Fiscal Year 2022

NeuBase Therapeutics Reports Business Update and Financial Results for the Second Quarter of Fiscal Year 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesJessica yinglingNeubase therapeuticsneubaseDan ferrymanaging directorlifesciDietricha stephanDrug administrationGood laboratory practiceHuntington disease hd programNeubase therapeutics incExchange commissionOncology programAmerican society of genePh dlittle dog communications incNew drugAmerican society

NeuBase Therapeutics Reports Business Update and Financial

Investigational New Drug (IND)-enabling studies for the myotonic dystrophy type 1 (DM1) program development candidate continue as planned; invited to.

United kingdomJessica yinglingToddp branningDietricha stephanLifesci advisorsLittle dog communications incDrug administrationGood laboratory practiceHuntington disease hd programNeubase therapeutics incExchange commissionOncology programInvestigational new drugManufacturing practiceChief financial officerBase therapeutics

NeuBase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2021

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United kingdomUnited statesJessica yinglingWilliam mannSandra rojas caroTony rossomandoDietricha stephanLifesci advisorsLittle dog communications incVera therapeutics incDrug administrationHuntington disease hd programNeubase therapeutics incExchange commissionOncology programBase therapeutics